Sort   by:  
 Page size 
GenomicsPlasmid spread from carbapenemase producing Enterobacter hormaechei ST79 from contaminated dicloxacillin capsules to other Enterobacterales
Plasmid spread from carbapenemase producing Enterobacter hormaechei ST79 from contaminated dicloxacillin capsules to other Enterobacterales
PRJEB81499 | ENA
UnknownDicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users.
Not available
S-EPMC11602906 | biostudies-literature
UnknownDicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.
Not available
S-EPMC5809358 | biostudies-literature
UnknownDicloxacillin and flucloxacillin inhibit hepatic uptake transporters -in vitro investigations and physiologically based pharmacokinetic modelling.
Not available
S-EPMC12633417 | biostudies-literature
UnknownBiosorption of dicloxacillin from pharmaceutical waste water using tannin from Indian almond leaf: Kinetic and equilibrium studies.
Not available
S-EPMC7305391 | biostudies-literature
TranscriptomicsResponse of methicillin-resistant Staphylococcus aureus USA300 to a subinhibitory concentration of thioridazine - alone and in combination with dicloxacillin
Subinhibitory concentrations of the neuroleptic drug thioridazine (TDZ) are well-known to enhance the killing of methicillin-resistant S. aureus (MRSA) by β-lactam antibiotics, however, the mechanism underlying the synergy between TDZ and β-lactams is not fully understood. In the present study we ...
ORGANISM(S): Staphylococcus aureus subsp. aureus USA300_FPR3757 
2013-05-20 | E-GEOD-43759 | biostudies-arrayexpress
UnknownSystemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity.
Not available
S-EPMC5344393 | biostudies-literature
ProteomicsDiscovery and visualization of uncharacterized drug-protein adducts using mass spectrometry
Drugs are often metabolized to reactive intermediates that form protein adducts. Adducts can inhibit protein activity, elicit immune responses, and cause life threatening adverse drug reactions. The masses of reactive metabolites are frequently unknown, rendering traditional mass spectrometry-based ...
ORGANISM(S): Homo sapiens (Human) Rattus norvegicus (Rat) 
2022-02-24 | PXD025019 | Pride
Magnum Raloxifene Dicloxacillin Adduct Plasma Cyp3a4 Open search Metamorpheus Comet Human serum albumin Msfragger Penicillin Moda Hsa Xenobiotic Reactive metabolite P450-reductase Flucloxacillin Open-pfind Comet-ptm Limelight 
UnknownA comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine.
Not available
S-EPMC4664062 | biostudies-literature
UnknownEffects of Antibiotics on the Intestinal Microbiota of Mice.
Not available
S-EPMC7235770 | biostudies-literature
Sort   by:  
 Page size